Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
Sales | 500,051 | 571,453 | 508,745 | 516,777 | 471,197 |
Cost of Goods | 229,988 | 256,755 | 229,276 | 236,545 | 207,168 |
Gross Profit | 270,063 | 314,698 | 279,469 | 280,232 | 264,029 |
Operating Expenses | 244,842 | 336,080 | 251,652 | 258,252 | 238,470 |
Operating Income | 26,209 | -20,627 | 28,093 | 22,525 | 25,727 |
Interest Expense | 5,316 | 6,534 | 5,634 | 5,632 | 5,580 |
Other Income | -746 | -1,026 | 229 | 9,971 | 48 |
Pre-tax Income | 20,147 | -28,187 | 22,688 | 26,864 | 20,195 |
Income Tax | 7,734 | -5,492 | 4,283 | 8,850 | 7,919 |
Net Income Continuous | 12,413 | -22,695 | 18,405 | 18,014 | 12,276 |
Net Income | $12,413 | $-22,695 | $18,405 | $18,014 | $12,276 |
EPS Basic Total Ops | 0.42 | -0.78 | 0.63 | 0.61 | 0.42 |
EPS Basic Continuous Ops | 0.42 | -0.77 | 0.63 | 0.61 | 0.42 |
EPS Diluted Total Ops | 0.41 | -0.77 | 0.62 | 0.61 | 0.42 |
EPS Diluted Continuous Ops | 0.42 | -0.77 | 0.62 | 0.61 | 0.42 |
EBITDA(a) | $59,909 | $-20,627 | $66,581 | $60,103 | $59,817 |